We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Crowdfunding Opportunities


Premium businessagent.com 2018 EIS
Business Agent* is an FCA approved aggregation and rating portal for equity and debt crowdfunding investments. AIM is shrinking, legacy stock markets are too expensive to maintain and do not serve the requirements of SMEs, banks are closing branches, lending less and are paying little or no interest to investors. As a result of this there is a huge growth in equity crowdfunding and P2P lending which has seen the launch of hundreds of alternative lenders & platforms that has created a new c.£3bn marketplace, expanding at 66% p.a. There is no single portal or trusted ratings index for investors to compare on a like for like basis and no secondary market to facilitate exits.   * NextFin is the new trading name of Business Agent Ltd The solution NextFin aggregates equity and debt crowdfunding investments to create the alternative finance marketplace. This makes it easy for investors and lenders to find and compare opportunities by presenting all investment offerings in one place. With the addition of a free of charge ratings service investors will be able to view ratings of every equity crowdfunding pitch, every P2P site, and every equity crowdfunding site. NextFin’s technology will constantly track these companies and investments providing the investor real-time intelligence on which to base investment decisions. The platforms and entrepreneurs will be self promoting and marketing their ratings driving thousands of visitors a month to the NextFin site, in the same way businesses refer their potential clients to Trip Advisor and Trustpilot. There is an estimated 10 million website/platform visitors per month across the whole of the alternative finance market. NextFin is targeting to direct 5% of this highly profiled traffic to its platform from which it will earn between £5-£8 per click from advertisers and partners. In addition an in-house brokerage service also earns between 1%-6% commissions on loan placements. A future revenue stream (not featured in the financials) will be developed once visitor traffic reaches critical mass. This will see Nextfin being able to realise the full value of its captured ratings data and visitor traffic by launching a secondary market, which is estimated to be a £5bn marketplace. NextFin is raising £500k at a pre-money valuation of £800k to: • Acquire CrowdRating for a non cash consideration of 20% equity• Develop P2P and Equity site ratings• Expand the management, infrastructure and marketing resource• Increase visitor traffic to 6m a year via rating referrals Owing to the size of the market and rapid growth of the industry, enterprise valuations in alternative finance are based on visitor traffic, market share and registered users. Recent published valuations of companies with visitor traffic of over 6m per year are in excess of £70m. NextFin is the market leading aggregator and has first mover advantage. It has the potential to exceed these valuations because it is the whole of market aggregator and is currently the only ratings service provider as it grows to achieve 500,000 visitors p.m.
investment: £202,055 target: £249,772
status: Active 5 days
to go
More Information
81%
Premium ABBS Technology
Advanced Blast & Ballistic Systems Ltd (ABBS) is a pioneer in developing a patented platform technology that has military applications in mine-blast protection and for eVTOL aircraft. The combined value of these projects is estimated to be around $80 Billion by 2035. Roger Sloman (founder) has worked inexhaustibly for 10 years to make civilian and military vehicles safer. The company’s market applications consist of the military, aid agency, mine clearance, and VIP vehicles. ABBS is also working with regulatory authorities around the world such as CAA (UK), EASA (Europe), and FAA (US) to ensure the highest safety level for unmanned flight technology.
investment: £139,624 target: £500,000
status: Active 5 days
to go
More Information
28%
Shuttout is a global community-driven photography marketplace that adds social significance to photographs and makes it more fit for sale. It uses features such as 'stock' (Shutterstock, 500px, Flickr), 'social media' (Instagram) and 'photo contest' (GuruShots, Viewbug) to create a unique selling environment. It started worldwide expansion, growth and user acquisition from 154 countries using Facebook and Google ads. It has also collaborated with YouTube Influencers including Rebecca Spencer (UK), Hanna Saba (Australia), and Saurav Sinha (India) to increase its userbase. Shuttout has started the facility for users to host contests by themselves. Since the launch in April 2018, it has reached 76,000+ users and has added 71,000+ photos to the platform. The platform aims to connect those who love taking photos and want to earn money from their passion with potential buyers. 
investment: £527,600 target: £550,004 pre-money valuation: £4,257,981
status: Active 12 days
to go
More Information
96%
Premium Diamond & Emerald Exchange Manufacturing and Retail EIS
Diamond & Emerald Exchange specialises in coloured gemstone trade and bespoke jewellery creation. It works with a decent business model designed to deliver high quality at below high street prices in both B2C and B2B markets. Diamond & Emerald Exchange has made a unique set of relationships with emerald suppliers in Colombia and South America. It has been awarded 'Best Diamonds & Emeralds Supplier 2018' at the UK Enterprise Awards and, it has gained an "Excellent" Trustpilot score of 5 stars. The company plans to use the raised capital to expand its sales team and develop its in-house marketing, digital marketing and advertising team.
investment: £54,470 target: £100,000
status: Active 42 days
to go
More Information
54%
ADC Biotechnology Limited Technology EIS
ADC Biotechnology provides specialist drug manufacturing services based on its own patented Lock-Release™ processing technology, focused on a new wave of oncology therapeutics called antibody-drug conjugates (“ADCs”) being developed by pharmaceutical companies worldwide.
investment: £6,243,502 target: £6,000,000 pre-money valuation: £60,666,667
status: Extended
More Information
104%
Prosperity House - 2x 2 Bed BTLs Housing and Property
These two high quality, two bedroom apartments have been completed as part of the first phase of development at Prosperity House. They have been provided by Prosperity at a signficant discount and have been taken up by an experienced LandLord who is also a CrowdLords member. The LandLord has a portfolio of 23 other properties in various locations around the country including one nearby in Nottingham. He has decided to offer Interim Equity for a period of 12 months after which time he will decide whether to sell or refinance the apartments. In return for their investment Investors enjoy a share of income and a share of any capital gain at the end of the investment term. With this investment the Income yield is paid quarterly and is projected to be 2.8% p.a. paid by way of Dividend, and the capital gain will be a share of 75% of the increase in vale, projected to combine to deliver a total return of 21.3%..
investment: £140,225 target: £143,800
status: Active
More Information
98%
Probe Technology EIS
Probe has developed microeye to change the way doctors take blood samples. Microeye provides a continous sample from venus blood without removing whole blood. When coupled with Probe’s continumon it gives the clinician continous data showing trends and rate of change.
investment: £233,630 target: £499,968 pre-money valuation: £5,049,066
status: Funded
More Information
47%
Bivictrix Therapeutics Limited Medical EIS SEIS
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
investment: £451,506 target: £430,000 pre-money valuation: £4,347,778
status: Extended
More Information
105%
Redag Crop Protection Limited Catering, Food and Drink EIS
Redag Crop is an agrochemical discovery business focused on products that play a vital role in controlling the pests and diseases that threaten our global food supply. The growing population, expected to grow by 8 billion by 2020 and then 9 billion by 2050, will need more crops than the existing land can produce. Each hectare will need to produce 2.5 times as many crops as they do now. 
investment: £1,250,000 target: £1,250,000 pre-money valuation: £12,638,889
status: Extended
More Information
100%
YProTech provide a specialist service for the pharmaceutical, biotechnology (life sciences) and applied chemical sectors. They provide a fast and reliable delivery of laboratory scale chemistry development services.
investment: £234,438 target: £134,000 pre-money valuation: £1,354,889
status: Extended
More Information
175%
 AskIf is platform that provides loan funding to small businesses. Each borrower has one or more relationship managers they can talk to. They are collecting data around social impact and are planning on monetising the data within their own business model and also to external stakeholders. AskIf will use the funding to expand referral partnership, increase the amount of their lending partners that are using the platform, make strong relationships to bring in new tech resource in house and bring in loan capital. 
investment: £668,753 target: £399,995 pre-money valuation: £3,001,323
status: Extended
More Information
167%
Severn Street - Interim Equity Housing and Property
An opportunity to invest in a central Birmingham new build development of premium one and two bedroom apartments. This significant development in a prime location will deliver 31 units to meet the needs of young professionals looking to rent in the city centre. The development will start this summer and is due to completed in Q1 2019. All units have been pre-sold by Prosperity to their investment buyers and will be delivered under a fixed price JCT contract. Prosperity are raising equity for the purchase of the site (Subject To Planning) and in return offering a fixed return of 13.5% p.a. using our Interim Equity arrangement. In return for an investment, holders of Redeemable Class B shares will receive 17.6% of their share of the profit which equates to around 16.8% of projected net profits after tax. This will be paid as a capital gain when the shares are redeemed at a price of £1.27 per share, on or before the 31st March 2019.
investment: £488,700 target: £488,700
status: Extended
More Information
100%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph